Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study

• Main Authors: Bahtiyar Yilmaz (Author), Lisa Ruckstuhl (Author), Beat Müllhaupt (Author), Lorenzo Magenta (Author), Melanie Harrer Kuster (Author), Olivier Clerc (Author), Ralph Torgler (Author), Nasser Semmo (Author)
• Format: Book
• Published: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In this small pilot sub-study, longitudinal gut microbiota composition changes, after successful treatment of hepatitis C virus (HCV) with the co-formulated glecaprevir/pibrentasvir (GLE/PIB), were analyzed before treatment (baseline) and 12 weeks post-treatment. Participating patients provided a fr...